Wolverine Trading, LLC Theravance Biopharma, Inc. Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 11, 2020	SELL	$17.84 - $31.21 $151,640 - $265,285	-8,500 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$16.12 - $25.89 $137,020 - $220,065	8,500 New	8,500 $220,000
Q3 2018 Nov 14, 2018	SELL	$22.83 - $32.67 $356,148 - $509,652	-15,600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$23.37 - $29.71 $46,740 - $59,420	2,000 Added 14.71%	15,600 $378,000
Q4 2017 Feb 14, 2018	BUY	$25.82 - $35.66 $162,666 - $224,657	6,300 Added 86.3%	13,600 $379,000
Q3 2017 Nov 15, 2017	BUY	$23.88 - $34.96 $174,324 - $255,208	7,300	7,300 $250,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.